XML 65 R34.htm IDEA: XBRL DOCUMENT
v3.25.3

SHAREHOLDERS’ EQUITY (Tables) | 12 Months Ended
--- | ---
Jul. 31, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items] |
SCHEDULE OF CHANGE IN FAIR VALUE OF WARRANTS | SCHEDULE OF CHANGE IN FAIR VALUE OF WARRANTS
|  | Warrants liability |
Balance as of July 31, 2023 |  |  | 29,139,301 |
Fair value of BriaPro Warrant Shares at Effective Date (note 1(e)) |  |  | 199,207 |
Change in fair value during the year |  |  | (28,242,472 | )
Balance as of July 31, 2024 |  | $ | 1,096,036 |
Change in fair value during the year |  |  | (758,364 | )
Balance as of July 31, 2025 |  | $ | 337,672 |
| (*) | Certain warrants were issued prior to August 1, 2022 in respect of public offerings and private placements that contain terms that require the warrants to be recorded as a liability at fair value under US GAAP. As a result, these warrants are valued at the end of each reporting period. For the year ended July 31, 2025, the Company recorded a gain on the revaluation of the total warrant liability of $758,364 in the consolidated statements of operations and comprehensive loss.
|  | The key inputs used in the valuation of the of the warrant as of July 31, 2025 and at July 31, 2024 and on the issuance dates, were as follows:
SCHEDULE OF VALUATION OF PUBLIC OFFERING BROKER WARRANTS | SCHEDULE OF VALUATION OF PUBLIC OFFERING BROKER WARRANTS
|  | February 26, 2021 (Issuance date) |  |  | April 12, 2021 (Issuance date) |  |  | July 31, 2025 |  |  | July 31, 2024 |
Share price |  | $ | 510 |  |  | $ | 588 |  |  | $ | 7.50 |  |  | $ | 112.50 |
Exercise price |  | $ | 796.88 |  |  | $ | 796.88 |  |  |  | 796.88-928.50 |  |  | $ | 796.88-928.50 |
Expected life (years) |  |  | 5.00 |  |  |  | 5.00 |  |  |  | 0.57-1.35 |  |  |  | 1.57-2.35 |
Volatility |  |  | 100 | % |  |  | 100 | % |  |  | 157-209 | % |  |  | 77-79 | %
Dividend yield |  |  | 0 | % |  |  | 0 | % |  |  | 0 | % |  |  | 0 | %
Risk free rate |  |  | 0.88 | % |  |  | 0.97 | % |  |  | 4.10 | % |  |  | 4.27 | %
SCHEDULE OF BRIA PRO WARRANTS | The key inputs used in the valuation of the of the BriaPro Warrant Shares as of July 31, 2025 were as follows: SCHEDULE OF BRIA PRO WARRANTS
|  |  |  |  | August 31, |
|  | July, 31 |  |  | 2023 |
|  | 2025 |  |  | (Effective Date) |
Share price |  | $ | 0.0365 |  |  | $ | 0.0365 |
Exercise price |  | $ | 0.0206-0.0308 |  |  | $ | 0.0206-0.0308 |
Expected life (years) |  |  | 0.30-1.35 |  |  |  | 2.21-3.27 |
Volatility |  |  | 157-209 | % |  |  | 100 | %
Dividend yield |  |  | 0 | % |  |  | 0 | %
Risk free rate |  |  | 2.68-2.74 | % |  |  | 4.40 | %
Share Purchase Warrants [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
SUMMARY OF CHANGES IN WARRANTS | A summary of changes in share purchase warrants for the years ending July 31, 2025 and 2024 is presented below: SCHEDULE OF CHANGES IN WARRANTS
|  | Number of options outstanding |  |  | Weighted average exercise price (*) |
Balance, July 31, 2023 |  |  | 54,144 |  |  | $ | 863.18 |
Granted in the May 2024 Offering |  |  | 16,019 |  |  |  | 316.50 |
Balance, July 31, 2024 |  |  | 70,163 |  |  | $ | 738.36 |
Exercised |  |  | (6,437 | ) |  |  | 127.50 |
Granted in the October 2024 Offering |  |  | 34,190 |  |  |  | 127.50 |
Granted in the December 2024 Offering |  |  | 49,333 |  |  |  | 140.63 |
Granted in the April 2025 Offering |  |  | 306,665 |  |  |  | 52.50 |
Granted in the July 2025 Offering |  |  | 1,200,000 |  |  |  | 15.00 |
Balance, July 31, 2025 |  |  | 1,653,914 |  |  | $ | 58.27 |
(*) | See note 7(a).
SCHEDULE OF WARRANTS OUTSTANDING | As of July 31, 2025, warrants outstanding were as follows: SCHEDULE OF WARRANTS OUTSTANDING
Number of Warrants |  |  | Exercise Price |  |  | Exercisable At July 31, 2025 |  |  | Expiry Date
| (*)346 |  |  | $ | 588.62 |  |  |  | 346 |  |  | November 16, 2025
| (*)25,978 |  |  | $ | 796.88 |  |  |  | 25,978 |  |  | February 26, 2026 – April 26, 2026
| (*)27,820 |  |  | $ | 928.50 |  |  |  | 27,820 |  |  | December 7, 2026
| 16,019 |  |  | $ | 316.50 |  |  |  | 16,019 |  |  | November 17, 2029
| 27,753 |  |  | $ | 127.50 |  |  |  | 27,753 |  |  | October 2, 2029
| 49,333 |  |  | $ | 140.63 |  |  |  | 49,333 |  |  | December 12, 2029
| 306,665 |  |  | $ | 52.50 |  |  |  | 306,665 |  |  | April 28, 2030
| 1,200,000 |  |  | $ | 15 |  |  |  | 1,200,000 |  |  | July 15, 2030
| 1,653,914 |  |  |  |  |  |  |  | 1,653,914 |  |  |
(*) | Briacell Legacy Warrants – see note 1(d) and note 7(a)
Compensation Warrants [Member] |
Accumulated Other Comprehensive Income (Loss) [Line Items] |
SUMMARY OF CHANGES IN WARRANTS | A summary of changes in compensation warrants for the years ended July 31, 2025 and 2024 is presented below: SUMMARY OF CHANGES IN WARRANTS
|  | Number of warrants outstanding |  |  | Weighted average exercise price (*) |
Balance, July 31, 2023 |  |  | 311 |  |  |  | 843.52 |
Granted in the May 2024 Offering |  |  | 333 |  |  |  | 348.00 |
Balance, July 31, 2024 |  |  | 644 |  |  |  | 587.30 |
Granted in the September 2024 Offering |  |  | 4,108 |  |  |  | 129.38 |
Granted in the October 2024 Offering |  |  | 1,709 |  |  |  | 182.81 |
Granted in the December 2024 Offering |  |  | 2,466 |  |  |  | 140.63 |
Granted in the February 2025 Offering |  |  | 3,812 |  |  |  | 50.00 |
Granted in the April 2025 Offering |  |  | 15,333 |  |  |  | 52.50 |
Balance, July 31, 2025 |  |  | 28,072 |  |  | $ | 91.35 |
(*) | See note 7(a).
SCHEDULE OF WARRANTS OUTSTANDING | As of July 31, 2025, compensation warrants outstanding were as follows: SCHEDULE OF WARRANTS OUTSTANDING
Number of Warrants |  |  | Exercise Price |  |  | Exercisable At July 31, 2025 |  |  | Expiry Date
| (*)34 |  |  | $ | 588.62 |  |  |  | 34 |  |  | November 16, 2025
| (*)113 |  |  | $ | 796.88 |  |  |  | 113 |  |  | February 26, 2026
| (*)164 |  |  | $ | 928.50 |  |  |  | 164 |  |  | June 7, 2026
| 333 |  |  | $ | 348.00 |  |  |  | 333 |  |  | May 17, 2029
| 4,108 |  |  | $ | 129.38 |  |  |  | 4,108 |  |  | September 12, 2029
| 1,709 |  |  | $ | 182.81 |  |  |  | 1,709 |  |  | October 2, 2029
| 2,466 |  |  | $ | 140.63 |  |  |  | 2,466 |  |  | December 12, 2029
| 3,812 |  |  | $ | 50.00 |  |  |  | 3,812 |  |  | February 5, 2030
| 15,333 |  |  | $ | 56.50 |  |  |  | 15,333 |  |  | April 28, 2030
| 28,072 |  |  |  |  |  |  |  | 28,072 |  |  |
(*) | Briacell Legacy Warrants – see note 1(d) and note 7(a)

X
- Definition Schedule Of Bria Pro Warranty [Table Text Block] + References No definition available. + Details
Name: | BCTX_ScheduleOfBriaProWarrantyTableTextBlock
Namespace Prefix: | BCTX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Changes In Fair Value Of Warrants [Table Text Block] + References No definition available. + Details
Name: | BCTX_ScheduleOfChangesInFairValueOfWarrantsTableTextBlock
Namespace Prefix: | BCTX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Changes In Warrants [Table Text Block] + References No definition available. + Details
Name: | BCTX_ScheduleOfChangesInWarrantsTableTextBlock
Namespace Prefix: | BCTX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Non Public Warranty [Table Text Block] + References No definition available. + Details
Name: | BCTX_ScheduleOfNonPublicWarrantyTableTextBlock
Namespace Prefix: | BCTX_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480870/815-30-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 4 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-4 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_AccumulatedOtherComprehensiveIncomeLossLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_SharePurchaseWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementEquityComponentsAxis=BCTX_CompensationWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |